Last reviewed 2026-04-19 · How we verify

Entacapone & Propranolol

Satish R. Raj · Phase 1 active Small molecule

Entacapone & Propranolol is a Small molecule drug developed by Satish R. Raj. It is currently in Phase 1 development. Also known as: Comtan, Inderal.

Likelihood of approval

9.6% vs 9.6% industry baseline

If approved by FDA: likely 2033–2036

Steps remaining: Phase 2 → Phase 3 → NDA/BLA submission

Confidence: Medium

Why this estimate

Baseline phase 1 → approval rate +9.6pp
Industry-wide phase 1 drugs reach approval ~9.6% of the time (BIO/Informa 2023 industry benchmark across all therapeutic areas).

Predicted approval windows by jurisdiction (conditional on FDA approval)

Regulator	Country	Likely year	Lag vs FDA
FDA	US	2033–2036	—
EMA	EU	2034–2037	+0.7 yr
MHRA	GB	2034–2037	+0.7 yr
Health Canada	CA	2034–2038	+0.9 yr
TGA	AU	2034–2038	+1.2 yr
PMDA	JP	2034–2038	+1.5 yr
NMPA	CN	2035–2039	+2.3 yr
MFDS	KR	2034–2038	+1.4 yr
CDSCO	IN	2034–2039	+1.8 yr
ANVISA	BR	2035–2039	+2.3 yr

Hover any row for the lag rationale. Lag estimates are reduced when the drug has FDA Breakthrough or EMA PRIME designation (sponsors file globally in parallel).

Estimate based on the BIO/Informa industry phase transition rates plus per-drug modifiers for therapeutic area, sponsor type, FDA designations, mechanism, and trial design. Per-jurisdiction lags from Tufts CSDD international approval studies. Not investment, clinical or regulatory advice. Methodology: /methodology#likelihood.

At a glance

Generic name	Entacapone & Propranolol
Also known as	Comtan, Inderal
Sponsor	Satish R. Raj
Modality	Small molecule
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Entacapone & Propranolol CI brief — competitive landscape report
Entacapone & Propranolol updates RSS · CI watch RSS
Satish R. Raj portfolio CI

Frequently asked questions about Entacapone & Propranolol

What is Entacapone & Propranolol?

Entacapone & Propranolol is a Small molecule drug developed by Satish R. Raj.

Who makes Entacapone & Propranolol?

Entacapone & Propranolol is developed by Satish R. Raj (see full Satish R. Raj pipeline at /company/satish-r-raj).

Is Entacapone & Propranolol also known as anything else?

Entacapone & Propranolol is also known as Comtan, Inderal.

What development phase is Entacapone & Propranolol in?

Entacapone & Propranolol is in Phase 1.

Manufacturer: Satish R. Raj — full pipeline
Also known as: Comtan, Inderal

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing